Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pines, A.
Right arrow Articles by Frankl, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pines, A.
Right arrow Articles by Frankl, O.

Chest, Vol 88, 129-135, Copyright © 1985 by American College of Chest Physicians

ARTICLES

Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications

A Pines, N Kaplinsky, D Olchovsky, J Rozenman and O Frankl

Correct identification of the subsets of pulmonary lupus has an unquestioned importance in planning the proper therapeutic regimen in this extremely variegated disease. Asymptomatic pulmonary lupus needs no treatment; however, pulmonary involvement in lupus may be life threatening, in which case prompt and aggressive treatment is mandatory. The different aspects of pulmonary lupus are demonstrated through the clinical histories of patients who suffered from pleuro- pulmonary lupus. The following entities are presented: lupus pneumonitis, lymphocytic interstitial pneumonia, pulmonary hypertension, pulmonary hemorrhage, pulmonary embolism associated with circulating lupus anticoagulant, lupus pleuritis and weakness of the diaphragm.


This article has been cited by other articles:


Home page
 ChestHome page
H. K. Koller, O. C. Burghuber, and D. Kiss
Pulmonary Manifestation of Systemic Lupus Erythematosus (SLE) with normal High Resolution Computer Tomography
Chest Meeting Abstracts, October 1, 2004; 126(4): 971S - 971S.
[Abstract] [PDF]

Home page
 Postgrad. Med. J.Home page
A G Rockall, D Rickards, and P J Shaw
Imaging of the pulmonary manifestations of systemic disease
Postgrad. Med. J., October 1, 2001; 77(912): 621 - 638.
[Full Text] [PDF]

Home page
 ChestHome page
A. S. Santos-Ocampo, B. F. Mandell, and B. J. Fessler
Alveolar Hemorrhage in Systemic Lupus Erythematosus : Presentation and Management
Chest, October 1, 2000; 118(4): 1083 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
T L.-T. Pan, J Thumboo, and M-L Boey
Primary and secondary pulmonary hypertension in systemic lupus erythematosus
Lupus, June 1, 2000; 9(5): 338 - 342.
[Abstract] [PDF]

Home page
 ChestHome page
I. M. Robbins, S. P. Gaine, R. Schilz, V. F. Tapson, L. J. Rubin, and J. E. Loyd
Epoprostenol for Treatment of Pulmonary Hypertension in Patients With Systemic Lupus Erythematosus*
Chest, January 1, 2000; 117(1): 14 - 18.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.